Epigenetic protein families: a new frontier for drug discovery

CH Arrowsmith, C Bountra, PV Fish, K Lee… - Nature reviews Drug …, 2012 - nature.com
Epigenetic regulation of gene expression is a dynamic and reversible process that
establishes normal cellular phenotypes but also contributes to human diseases. At the …

The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses

AK Ghosh, A Sarkar, M Brindisi - Organic & biomolecular chemistry, 2018 - pubs.rsc.org
The Curtius rearrangement is a versatile reaction in which a carboxylic acid can be
converted to an isocyanate through an acyl azide intermediate under mild conditions. The …

Iridium‐Catalyzed Enantioselective C(sp3)−H Borylation of Aminocyclopropanes

Y Shi, Y Yang, S Xu - Angewandte Chemie, 2022 - Wiley Online Library
Transition‐metal‐catalyzed regio‐and stereo‐controllable C− H functionalization remains a
formidable challenge in asymmetric catalysis. Herein, we disclose the first example of …

Methods for the synthesis of donor-acceptor cyclopropanes

YV Tomilov, LG Menchikov, RA Novikov… - Russian Chemical …, 2018 - iopscience.iop.org
The interest in cyclopropane derivatives is caused by the facts that, first, the three-carbon
ring is present in quite a few natural and biologically active compounds and, second …

Lysine demethylases inhibitors

T Suzuki, N Miyata - Journal of medicinal chemistry, 2011 - ACS Publications
Recent studies have revealed that chromatin remodeling, caused by DNA methylation and
histone modifications such as acetylation, methylation, and phosphorylation, plays a pivotal …

Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway

GR Sareddy, S Viswanadhapalli, P Surapaneni… - Oncogene, 2017 - nature.com
Glioma stem cells (GSCs) have a central role in glioblastoma (GBM) development and
chemo/radiation resistance, and their elimination is critical for the development of efficient …

TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy

YC Zheng, B Yu, ZS Chen, Y Liu, HM Liu - Epigenomics, 2016 - Taylor & Francis
Since the first lysine-specific demethylase (KDM), lysine-specific demethylase 1 (LSD1), was
characterized in 2004, several families of KDMs have been identified. LSD1 can specifically …

Stereodivergent Synthesis of Arylcyclopropylamines by Sequential C H Borylation and Suzuki–Miyaura Coupling

S Miyamura, M Araki, T Suzuki… - Angewandte …, 2015 - Wiley Online Library
A step‐economical and stereodivergent synthesis of privileged 2‐arylcyclopropylamines
(ACPAs) through a C (sp3) H borylation and Suzuki–Miyaura coupling sequence has been …

Histone lysine demethylase inhibitors

A Jambhekar, JN Anastas, Y Shi - Cold Spring …, 2017 - perspectivesinmedicine.cshlp.org
The dynamic regulation of covalent modifications to histones is essential for maintaining
genomic integrity and cell identity and is often compromised in cancer. Aberrant expression …

Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism.

D Ogasawara, Y Itoh, H Tsumoto… - Angewandte …, 2013 - search.ebscohost.com
Drug drop off: Given that lysine‐specific demethylase 1 (LSD1) could be potently and
selectively inactivated by delivering phenylcyclopropylamine (PCPA), a weak and …